Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 2, 2012
Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs
Peter Manu, Christoph U Correll, Martien Wampers, et al.
Schizophrenia Research
|
March 6, 2007
Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities
Christoph U Correll, Jean L Harris, Rudy A Pantaleon Moya, et al.
Journal of Affective Disorders
|
March 22, 2016
The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis
Brendon Stubbs, Davy Vancampfort, Nicola Veronese, et al.
Plos One
|
September 13, 2019
Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study
Alex J Mitchell, Davy Vancampfort, Peter Manu, et al.
The Psychiatric Quarterly
|
June 10, 2015
Erratum to: Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Schizophrenia Research
|
December 13, 2012
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Peter Manu, Christoph U Correll, Martien Wampers, et al.
The Psychiatric Quarterly
|
March 23, 2015
Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Psychiatry Research
|
June 20, 2024
Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking
Jurjen J Luykx, Antti Tanskanen, Markku Lähteenvuo, et al.
Comprehensive Psychiatry
|
April 24, 2012
Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention
Peter Manu, Muhammad Asif, Sameer Khan, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 25, 2008
The QTc interval and its dispersion in patients receiving two atypical antipsychotics
Christoph U Correll, Anne M Frederickson, Vicki Figen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 2, 2012
Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs
Peter Manu, Christoph U Correll, Martien Wampers, et al.
Schizophrenia Research
|
March 6, 2007
Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities
Christoph U Correll, Jean L Harris, Rudy A Pantaleon Moya, et al.
Journal of Affective Disorders
|
March 22, 2016
The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis
Brendon Stubbs, Davy Vancampfort, Nicola Veronese, et al.
Plos One
|
September 13, 2019
Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study
Alex J Mitchell, Davy Vancampfort, Peter Manu, et al.
The Psychiatric Quarterly
|
June 10, 2015
Erratum to: Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Schizophrenia Research
|
December 13, 2012
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Peter Manu, Christoph U Correll, Martien Wampers, et al.
The Psychiatric Quarterly
|
March 23, 2015
Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Psychiatry Research
|
June 20, 2024
Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking
Jurjen J Luykx, Antti Tanskanen, Markku Lähteenvuo, et al.
Comprehensive Psychiatry
|
April 24, 2012
Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention
Peter Manu, Muhammad Asif, Sameer Khan, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
June 25, 2008
The QTc interval and its dispersion in patients receiving two atypical antipsychotics
Christoph U Correll, Anne M Frederickson, Vicki Figen, et al.
Page
of 10